Skip to content

Clinical trials

Completed Bone Diseases, Metabolic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Status: Completed Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20042
20062
20123
20131
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Novartis Pharmaceuticals2
Alphatec Spine, Inc.1
AstraZeneca1
Institut Straumann AG1
Ligand Pharmaceuticals1
Tameside General Hospital1
University of Surrey1
Warner Chilcott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic11
Osteoporosis6
Bone Diseases2
Breast Neoplasms2
Musculoskeletal Diseases2
Osteoporosis, Postmenopausal2
Constriction, Pathologic1
Coronary Artery Disease1
Diabetic Angiopathies1
Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.